SANDRA
RODRÍGUEZ PERALES
Profesora asociada
Institució Catalana de Recerca i Estudis Avançats
Barcelona, EspañaPublicaciones en colaboración con investigadores/as de Institució Catalana de Recerca i Estudis Avançats (13)
2023
-
A human genome editing–based MLL::AF4 ALL model recapitulates key cellular and molecular leukemogenic features
Blood, Vol. 142, Núm. 20, pp. 1752-1756
-
Comprehensive characterization of a novel, oncogenic and targetable SEPTIN6::ABL2 fusion in T-ALL
British Journal of Haematology
2022
2020
-
Impaired condensin complex and Aurora B kinase underlie mitotic and chromosomal defects in hyperdiploid B-cell ALL
Blood, Vol. 136, Núm. 3, pp. 313-327
-
In vivo CRISPR/Cas9 targeting of fusion oncogenes for selective elimination of cancer cells
Nature Communications, Vol. 11, Núm. 1
-
Robustness of Catalytically Dead Cas9 Activators in Human Pluripotent and Mesenchymal Stem Cells
Molecular Therapy - Nucleic Acids, Vol. 20, pp. 196-204
2018
-
CRISPR/Cas9 for cancer therapy: Hopes and challenges
Biomedicines, Vol. 6, Núm. 4
-
Germline mutations in the spindle assembly checkpoint genes BUB1 and BUB3 are infrequent in familial colorectal cancer and polyposis
Molecular Cancer
2017
-
Efficient Recreation of t(11;22) EWSR1-FLI1+ in Human Stem Cells Using CRISPR/Cas9
Stem Cell Reports, Vol. 8, Núm. 5, pp. 1408-1420
-
Generation and characterization of a human iPSC cell line expressing inducible Cas9 in the “safe harbor” AAVS1 locus
Stem Cell Research, Vol. 21, pp. 137-140
-
Modeling mixed-lineage-rearranged leukemia initiation in CD34+ cells: A “CRISPR” solution
Haematologica
2016
-
Development Refractoriness of MLL-Rearranged Human B Cell Acute Leukemias to Reprogramming into Pluripotency
Stem Cell Reports, Vol. 7, Núm. 4, pp. 602-618
2015
-
A mutation in the POT1 gene is responsible for cardiac angiosarcoma in TP53-negative Li-Fraumeni-like families
Nature Communications, Vol. 6